Morató, X.; Pytel, V.; Jofresa, S.; Ruiz, A.; Boada, M.
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach. Int. J. Mol. Sci. 2022, 23, 9305.
https://doi.org/10.3390/ijms23169305
AMA Style
Morató X, Pytel V, Jofresa S, Ruiz A, Boada M.
Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach. International Journal of Molecular Sciences. 2022; 23(16):9305.
https://doi.org/10.3390/ijms23169305
Chicago/Turabian Style
Morató, Xavier, Vanesa Pytel, Sara Jofresa, AgustÃn Ruiz, and Mercè Boada.
2022. "Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach" International Journal of Molecular Sciences 23, no. 16: 9305.
https://doi.org/10.3390/ijms23169305
APA Style
Morató, X., Pytel, V., Jofresa, S., Ruiz, A., & Boada, M.
(2022). Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach. International Journal of Molecular Sciences, 23(16), 9305.
https://doi.org/10.3390/ijms23169305